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Abstract
This study reports on novel fast-dissolving core-shell composite microparticles of quercetin fabricated using coaxial
electrospraying. A PVC-coated concentric spinneret was developed to conduct the electrospray process. A series of analyses
were undertaken to characterize the resultant particles in terms of their morphology, the physical form of their components,
and their functional performance. Scanning and transmission electron microscopies revealed that the microparticles had
spherical morphologies with clear core-shell structure visible. Differential scanning calorimetry and X-ray diffraction verified
that the quercetin active ingredient in the core and sucralose and sodium dodecyl sulfate (SDS) excipients in the shell
existed in the amorphous state. This is believed to be a result of second-order interactions between the components; these
could be observed by Fourier transform infrared spectroscopy. In vitro dissolution and permeation studies showed that the
microparticles rapidly released the incorporated quercetin within one minute, and had permeation rates across the
sublingual mucosa around 10 times faster than raw quercetin.
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Introduction
Nanomedicine aims to develop structures with dimensions on
the nanometer scale, leading to medical materials with properties
significantly different from those prepared on larger scales [1–2].
One of the most popular micro-/nano- structures is the core-shell
structure (with different exterior and interior), in which the shell
can perform a number of functions. These include: protection of
the core from the outside environment; aiding in maintaining the
nanomaterial’s compositional and structural integrity; preventing
the core from aggregating or sintering into larger particles;
controlling selective percolation of molecules in and out of the
interior of the material; or, increasing solubility and/or biocom-
patibility [1,3,4]. It is often thought that the bottom-up approaches
are more suitable than top-down approaches for the synthesis of
core-shell structures [5]. However, coaxial electrohydrodynamic
atomization processes (EHDA, including electrospinning, electro-
spray and e-jet printing [6,7]) have successfully been used to
generate core-shell nanostructures from the macro-scale template
of a concentric spinneret, for instance in the preparation of core-
sheath nanofibers by electrospinning [8-10].
EHDA functions by dint of the fact that liquids can readily
interact with electrical energy [11]. This energy is exploited to dry
and solidify micro-fluid jets, causing solvent evaporation and
producing micro-/nano- size products very rapidly (often on the
order of 1022 s). This approach has been widely used to prepare
nanofibers using electrospinning [12–17]. Provided favorable
secondary interactions exist between them, the physical state of
the components in the solutions may be propagated into the solid
products without phase separation. Additionally, as a result of the
very fast drying process, the macroscale structure of the spinneret
is reproduced in the products on the microscale. Thus, the
concentric spinneret used for coaxial electrospinning results in
core/shell fibers with the components in the sheath and core fluids
almost entirely confined in one region of the fiber, and minimal
diffusion from one to another [18]. This has made EHDA a
powerful tool for developing micro-/nano- materials for biomed-
ical applications. A notable example involves the dissolution and
permeation of poorly water soluble drugs, a long-standing
challenge in pharmaceutics [19]. A range of electrospun
nanofibers (both monolithic and core-sheath) have been prepared
to ameliorate this commonly-encountered problem, and found to
exhibit excellent performance in enhancing dissolution rates
[20,21].
Over the past few years, single fluid electrospraying has been
explored in the preparation of drug-loaded systems with both
sustained and rapid drug release profiles [22–27]. Use of a coaxial
electrospraying process, in which a concentric spray head can
accommodate two different liquids, results in new possibilities in
the materials which can be generated. Akin to coaxial electro-
spinning it should permit the generation of solid products from
solutions which are not processable using a single fluid method,
provided that processable shell fluids are used to drive the
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formation of a core-shell structure. Using this process, Loscertales
et al. first reported the preparation of microparticles with a droplet
encapsulated in a polymer shell in 2002 [28]. There are many
reports of coaxial electrospinning being exploited to create core-
sheath nanofibers in which an electrospinnable sheath fluid
encapsulates a core liquid which cannot be electrospun alone [29].
Fast-dissolving drug delivery systems (FDDS) are an alternative
to conventional oral solid dosage forms [30,31]. They enhance the
efficacy of active pharmaceutical ingredients by ensuring their very
rapid dissolution (within one minute) in the oral cavity. This
happens immediately after contact with saliva, with neither
chewing nor additional water needed for administration [32,33].
FDDS have wide ranging applications in a variety of patients such
as children and the elderly, those who are bedridden, plus those
suffering from vomiting, diarrhea, rapid-onset allergic attacks or
central nervous system disorders. They are also useful in localised
therapies (such as local anesthetics for toothaches, oral ulcers, cold
sores or teething) and increase the ease of taking medicines while
traveling and for patients with restricted water intake [34]. The
demand for FDDS has increased rapidly in recent years. Oral
FDDS have been prepared in a range of formulations, including
fast-disintegrating tablets, capsules, strips, and membranes [35–
37].
Quercetin is a plant pigment (flavonoid) found in many plants
and foods. It is used for treating diabetes and conditions of the
heart and blood vessels and, and has been indicated for preventing
cancer, treating chronic infections of the prostate and increasing
endurance and improving athletic performance [38,39]. In
Chinese traditional medicine, quercetin is often used to prevent
asthma, eliminate phlegm and relieve a cough. A fast dissolving
quercetin formulation with very rapid onset of action after oral
administration would be highly useful to enhance patient
convenience. However, quercetin has poor solubility and a high
melting point, which makes the development of such systems
challenging. Very few studies into improving the dissolution of
quercetin using traditional pharmaceutical protocols have been
reported. It is also impossible to prepare amorphous quercetin-
polymer nanocomposites directly through single fluid EHDA
because there is a lack of solvent systems where both i) quercetin is
sufficiently soluble for formulation development and ii) EHDA
processing is possible [40].
In this paper, novel core-shell microparticles permitting the
rapid dissolution of quercetin were fabricated using coaxial
electrospraying. Unprocessable solutions of a polymer and
quercetin were encapsulated in a processable solution comprising
a polymer (polyvinylpyrrolidone, PVP) and other excipients
(sodium dodecyl sulfate (SDS), and sucralose). The resultant
core-shell microspheres contained multiple components with each
having an individual spatial deposition; the latter significantly
influence the materials’ functional characteristics, and are highly
tunable.
Materials and Methods
Materials
PVP K25 (Mw=30,000) was purchased from the Sigma-Aldrich
Co. Ltd. (Shanghai, China). Quercetin (purity .98%, No. -
MUST-12072505) was purchased from the Beijing Aoke Biolog-
ical Technology Co. Ltd. (Beijing, China). Sucralose, methylene
blue, and SDS were provided by the Sinopharm Chemical
Reagent Co., Ltd. (Shanghai, China). N, N-dimethylacetamide
(DMAc) and anhydrous ethanol were provided by the Shanghai
Shiyi Chemical Reagent Co., Ltd. (Shanghai, China). All
chemicals used were analytical grade. Water was double distilled
just before use.
Coaxial electrospraying
A mixed solution of 10% (w/v) PVP and quercetin in a mixed
solvent of dimethylacetamide (DMAc) : ethanol (4:6, v:v) was used
as the core fluid. The sheath liquid consisted of 10% (w/v) PVP,
0.2% (w/v) SDS and 0.3% (w/v) sucralose in a mixed solvent of
water : ethanol (0.5:9.5, v:v).
A homemade PVC-coated concentric spinneret was used to
carry out coaxial electrospraying. Two syringe pumps (KDS 100
and KDS 200, Cole-Parmer, Vernon Hills, IL, USA) were
employed to drive the shell and core fluids. A high voltage supply
(ZGF 60 kV/2 mA, Shanghai Sute Electrical Co., Ltd, Shanghai,
China) provided an applied voltage of 20 kV (this value was
selected following extensive optimization). All electrospraying
processes were carried out under ambient conditions (21uC64uC
with relative humidity 57%64%). The resultant microparticles
were collected on a metal collector wrapped with aluminum foil at
a fixed distance of 15 cm from the needle tip of the spinneret.
Experiments were recorded using a digital video recorder
(PowerShot A640, Canon, Japan) under 116magnification. The
microparticles obtained were dried for at least 24 h at 40uC under
vacuum (320 Pa) in a DZF-6050 electric vacuum drying oven
(Shanghai Laboratory Instrument Work Co. Ltd, Shanghai,
China) to facilitate the removal of residual organic solvent and
moisture. They were then stored in a desiccator before charac-
terization was undertaken. Details of the solutions used for EHDA
and the resultant processes are listed in Table 1.
Characterization
Morphology. The morphologies of the core-shell micropar-
ticles were assessed using an S-4800 field emission scanning
electron microscope (FESEM, Hitachi, Tokyo, Japan). Their
average sizes were determined by measuring the diameters of
more than 100 particles in FESEM images using the Image J
software (National Institutes of Health, Bethesda, MD, USA). The
topographies of the starting materials and products were observed
under cross-polarized light using an XP-700 polarized optical
microscope (Shanghai Changfang Optical Instrument Co. Ltd,
Shanghai, China). Transmission electron microscopy (TEM)
Table 1. Parameters used for electrospraying and details of
the particulate products.
No. Process Ccf
a (w/v) Fs
b (mL/h) Fc
c (mL/h) Cq
d (%) Diameter (mm)
M1 Single — 1.0 — 0 1.3560.67
M2 Coaxial 3% 1.0 0.4 7.64 1.6961.13
M3 Coaxial 3% 1.0 0.7 10.71 1.7461.02
M4 Coaxial 3% 1.0 1.0 — —
M5 Coaxial 5% 1.0 0.7 16.67 1.8560.83
aCcf represents the drug content in core fluid.
bFs represents the flow rate of sheath fluid that consists of 10% (w/v) PVP K25,
0.2% (w/v) SDS and 0.3% (w/v) sucralose in a mixed solvent system comprising
water and ethanol (0.5:9.5, v:v).
cFc represents the flow rate of core fluid that consists of 10% (w/v) PVP and
quercetin in a mixed solvent of DMAc and ethanol (4:6, v:v).
dCq represents the drug content in solid products, which is calculated according
to the equation: Cq = (Fc6Cc)/{ [Fs6(10%+0.2%+0.3%)]+ [Fc6(10%+Cc)]}, Fs, Fc,
and Cc represent the flow rates of the sheath and core fluids, and the drug
contents in the core fluids, respectively.
doi:10.1371/journal.pone.0092106.t001
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images of the samples were taken on a JEM 2100F field-emission
microscope (JEOL, Tokyo, Japan). TEM samples were prepared
by fixing a lacey carbon coated copper grid on the metal collector
and microparticles sprayed directly onto the grid.
Physical status of the components. Differential scanning
calorimetry (DSC) analyses were carried out using an MDSC 2910
differential scanning calorimeter (TA Instruments Co., New
Castle, DE, USA). Sealed samples were heated at 10uC min21
from ambient temperature (23uC) to 350uC under a nitrogen gas
flow of 40 ml min21. X-ray diffraction (XRD) was performed on a
D/Max-BR diffractometer (RigaKu, Tokyo, Japan) over the 2h
range of 5–60u using Cu Ka radiation at 40 mV and 30 mA.
Attenuated total reflectance Fourier transform infrared (ATR-
FTIR) spectra were recorded on a Nicolet-Nexus 670 FTIR
spectrometer (Nicolet Instrument Corporation, Madison, WI,
USA) over the range 500–4000 cm21 and at a resolution of
2 cm21. Approximately 5 mg of the materials were placed directly
on the diamond window for spectra acquisition.
In vitro dissolution and permeation tests. In vitro disso-
lution studies were carried out according to the Chinese
Pharmacopoeia (2010 Ed.). Dissolution studies were undertaken
following Method II, a paddle method, using a RCZ-8A apparatus
(Tianjin University Radio Factory, Tianjin, China). M2 (262 mg),
M3 (187 mg), M5 (120 mg), or 20 mg of crude quercetin (particle
size ,100 mm), were placed into 600 mL phosphate buffer (PBS,
pH6.8, 0.1 M) at 3761uC and at stirred at 50 rpm under sink
conditions (C,0.2 Cs). At predetermined time points, 5.0 mL
aliquots were withdrawn from the dissolution medium and
replaced with fresh medium to maintain a constant volume. After
filtration through a 0.22 mm membrane (Millipore, Billerica, MA,
USA) and appropriate dilution, the samples were analyzed at lmax
= 371 nm using a UV/vis spectrophotometer (UV-2102PC, Unico
Instrument Co. Ltd., Shanghai, China). The cumulative amount
of quercetin released was back-calculated from the data obtained
against a predetermined calibration curve. Each experiment
involved 6 replicates, and the results are expressed in percentage
terms as mean 6 SD.
In vitro permeation studies were performed using a RYJ-6A
Diffusion Test Apparatus (Shanghai Huanghai Drug Control
Instrument Co., Ltd., Shanghai, China). The materials under
study were mounted in six Keshary-Chien glass diffusion cells
surrounded by a water bath system that maintained a constant
temperature of 3760.2uC. Each cell had a diffusion area of
2.60 cm2 and the receptor compartment had a capacity of 7.2 mL.
Porcine sublingual mucosae obtained from a local abattoir
(Baoshan Jiangwan slaughterhouse, Shanghai, China) were
mounted between the donor and receptor compartments of the
diffusion cells with the mucosal surface uppermost. This occurred
within 2 hr of slaughtering. Each donor compartment was filled
with 1 ml PBS and the hydrodynamics in the receptor compart-
ment were maintained by stirring with a Teflon coated magnetic
bead at 100 rpm. The sublingual membranes were equilibrated
for 30 min before permeation tests. The M2 (1.31 mg), M3
(0.93 mg), or M5 (0.60 mg) materials, or 0.1 mg of crude
quercetin particles (,100 mm), were placed on the mucosal
surface. Samples (1 mL) were withdrawn from the receptor
compartment at timed intervals, filtered through a 0.22 mm
membrane (Millipore, Billerica, MA, USA) and absorption
Figure 1. Images of the coaxial electrospraying process and the spinneret. a) a diagram of the process; b) and c) the images of the
concentric PVC-coated spinneret.
doi:10.1371/journal.pone.0092106.g001
Figure 2. Photographs of the coaxial electrospraying process-
es. a) the arrangement of the apparatus used in this work (inset: a
photograph of the collector when an excessive core fluid flow rate was
used); b) the connection of the spinneret with the power supply; c) a
typical coaxial process under an applied voltage of 20 kV, with shell and
core flow rates of 1.0 and 0.7 mL h21respectively; d) the compound
Taylor cone.
doi:10.1371/journal.pone.0092106.g002
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measured at 371 nm as before. All measurements were carried out
six times.
Results and Discussion
The PVC-coated spinneret and coaxial electrospraying
Just as with electrospinning, an electrospraying system consists
of four major components: one or more syringe pumps, a high-
voltage power supply, a spinneret and a collector. A schematic
diagram of the coaxial electrospraying process is shown in
Figure 1a. The most significant modifications to the basic one-
fluid process concern the spinneret, changes to which allow
different procedures to be developed (e.g. coaxial electrospraying
or side-by-side electrospraying for generating Janus particles [41]).
Photographs of the homemade PVC-coated concentric spinneret
used are included in Figure 1b and 1c. This was prepared by
simply inserting a metal concentric spinneret consisting of stainless
steel tubes (with inner diameters of 0.84 and 0.21 mm respectively)
into a PVC tube (inner diameter 1.0 mm, length 30 mm).
Figure 3. FESEM images of the microparticles and their diameter distributions.
doi:10.1371/journal.pone.0092106.g003
Figure 4. TEM images. a) M1; b) M2; c) M3; and d) M5.
doi:10.1371/journal.pone.0092106.g004
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When coaxial electrospraying was carried out, two syringe
pumps were used to drive the shell and core fluids independently
(Figure 2a). A copper wire was used to connect the metal part of
the PVC-coated spinneret to the high voltage power supply
(Figure 2b). With an applied voltage of 20 kV, and shell and core
fluid flow rates of 1.0 and 0.4–0.7 mL h21 respectively, a
successful coaxial electrospraying process was observed
(Figure 2c). A straight thinning jet is emitted from the compound
Taylor cone (Figure 2d) and is followed by the explosion
atomization region. Increasing the core fluid to 1.0 mL h21
resulted in frequent penetration of the core solutions to the shell
fluids, and destruction of the collected microparticles (M4; see
inset of Figure 2a).
Quercetin not only has poor solubility in water, but also in
typical organic solvents such as methanol, ethanol, chloroform and
acetone. It dissolves easily in DMAc, but because of its high boiling
point (166uC) PVP solutions in DMAc cannot be directly
processed into solid microparticles using a single fluid electro-
spraying process. Thus a mixed solvent containing 40% DMAc
and 60% ethanol (v/v) was selected for preparing the drug-
polymer solutions. This still failed to directly generate solid
products using a single fluid process, however.
Inspired by coaxial electrospinning, where an electrospinnable
sheath fluid is often exploited to encapsulate an unspinnable core
fluid [29], we developed here an analogous coaxial electrospraying
process. In this, the shell fluid could be processed by single fluid
spraying and acted as a guide surrounding the (unsprayable) core.
A shell fluid consisting of 10% (w/v) PVP, 0.2% (w/v) SDS and
0.3% (w/v) sucralose in a mixed solvent of water : ethanol (0.5:9.5,
v:v) was able to ensure a smooth coaxial electrosraying process and
led to the formation of core-shell microparticles.
The PVC coating on the spinneret facilitates coaxial electro-
spraying in two respects: 1) being an antistatic polymer, PVC can
effectively retard the loss of electrical energy from the working
fluids to the environment and thus exploits the electrical field more
effectively; 2) the reduced interfacial intention between the PVC
and the shell working fluid (cf. between the metal spinneret and
fluid) makes it easier for the compound Taylor cone to form and
the straight fluid jets to be emitted. Recent reports have
demonstrated similar results in electrospinning using a Teflon-
coated spinneret [8] and in single fluid electrospraying using epoxy
resin [42].
Morphology
Single fluid electrospraying of the core fluid alone did not result
in solid products because of the high boiling point of DMAc,
whereas spraying the shell solution alone resulted in the
microparticles M1. These have an average diameter of
1.3560.67 mm (Figure 3). With core and shell flow rates of 0.4
or 0.7 and 1.0 mL h21, the core-shell microparticles M2 and M3
were generated. These respectively have average diameters of
1.6961.13 mm and 1.7461.02 mm (see Figure 3). This suggested
that the drug content in the microparticles could be varied by
increasing the flow rate of the drug-containing core fluid.
However, when the core flow rate was increased to 1.0 mL h21
in the preparation of M4, the core and shell fluids were found to
blend, resulting in the products collected being of poor quality.
Another route to increase the amount of drug in the
microparticles is to increase the drug concentration in the core
Figure 5. DSC thermograms of the starting materials (querce-
tin, sucralose, PVP and SDS) and microparticles (M2, M3 and
M5).
doi:10.1371/journal.pone.0092106.g005
Figure 6. XRD patterns and cross-polarised light observations. a) XRD patterns of the starting materials and microparticles; and, microscopy
images of b) quercetin; c) sucralose; d) SDS; e) PVP and f) M5 viewed under cross-polarised light.
doi:10.1371/journal.pone.0092106.g006
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fluids; M5 was thus prepared by increasing the quercetin content
from 3% to 5% (w/v) and using a core flow rate of 0.7 mL h21.
This raised the loading from 10.71% w/w (M3) to 16.67%. The
M5 particles have an average diameter of 1.8560.83 mm
(Figure 3). It is clear that an increase in core fluid flow rate from
0.4 to 0.7 mL h21 and the increase of drug concentration only
slightly enlarges the resultant microparticles.
Figure 4 shows TEM images of the electrosprayed products.
The M1 particles (from single fluid electrospraying) are observed
to be monolithic. The other three samples have clear core-shell
structures, with the shells a darker gray color because of the
presence of quercetin. The M2 particles have a thicker shell than
the M3 and M5 materials, as expected given the reduced core fluid
flow rate used to prepare the former. There is uniform gray
shading in both the shell and core parts of the microparticles in all
the images, indicating that quercetin is uniformly distributed in the
PVP matrix in the core and that SDS and sucralose are distributed
homogeneously in the shell.
Figure 7. ATR-FTIR spectra of the raw materials and microparticles, and the molecular structures of PVP, quercetin, sucralose and
SDS.
doi:10.1371/journal.pone.0092106.g007
Figure 8. In vitro dissolution tests. a) in vitro quercetin release profiles (n = 6); b) Photographs of the dissolution of M5. The process is shown in
sequence from 1 to 8, and finishes within 10s; c) a schematic depicting possible drug release mechanisms from the crystal quercetin and the
microparticle composites.
doi:10.1371/journal.pone.0092106.g008
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Physical form of the components
To improve the dissolution properties of poorly water soluble
drug, an amorphous physical form is favored [43]. Quercetin has a
very high melting point of 326uC, and thus there are few reports
on the generation of amorphous forms of this drug using
traditional melt and solvent evaporation methods. Similar to
electrospinning [10], electrospraying is an inherently appropriate
method for preparing amorphous dosage forms because of its
extreme drying speed. This is able to ‘freeze’ the drug molecules
randomly in the solid polymer matrix, maintaining them as a solid
solution comparable to the liquid form. If there exist stabilising
secondary interactions between the drug and the polymer matrix,
the amorphous drug can be easily fabricated and stored for
prolonged periods of time without relaxation to a crystalline form.
Differential scanning calorimetry (DSC) and X-ray diffraction
(XRD) experiments were undertaken to determine the physical
form of the components in the microparticles. The DSC
thermograms are shown in Figure 5. The DSC curves of pure
quercetin and sucralose both exhibit a single endothermic
response corresponding to their melting points of 130 and
326uC respectively. SDS has a melting point of 182uC followed
by a decomposition temperature of 213uC. Being an amorphous
polymer, PVP K25 does not show any fusion peaks or phase
transitions but does exhibit a broad endotherm due to dehydra-
tion; this lies between 80–120uC with a peak at 85uC. The DSC
thermograms of the three microparticle samples do not exhibit any
melting peaks. They instead show broad endotherms ranging from
ca. 60 to 100uC as a result of dehydration. The decomposition
bands of SDS are narrower and sharper than that of pure SDS,
and the exotherm maxima are shifted to lower temperatures.
These results suggest that quercetin, SDS and sucralose are
converted into the amorphous state in their respective parts of the
core-shell microparticles.
As shown in Figure 6a, the presence of numerous distinct
reflections in their XRD patterns proves that quercetin, sucralose
and SDS exist as crystalline materials. This is also demonstrated by
the observation of colorful images when these materials are viewed
under polarized light (Figure 6b to 6d). The PVP diffraction
pattern exhibits a diffuse background pattern with two diffraction
halos consistent with it being an amorphous polymer. The M2,
M3 and M5 particles exhibit none of the characteristic reflections
of the starting materials; instead their patterns comprise diffuse
haloes. In contrast to the observations of quercetin, SDS and
sucralose under polarized light, the analogous images of PVP and
M5 show no bright colors, suggesting both are amorphous
(Figure 6e and 6f). The combined DSC, XRD and light
microscopy results clearly verify that quercetin and the excipients
(sucralose and SDS) exist in the amorphous form in the
electrosprayed microparticles.
Secondary-interactions between components
Compatibility among the components is essential for producing
high quality and stable composite microparticles. Often second-
order interactions such as hydrogen bonding, electrostatic
interactions, and hydrophobic interactions can improve compat-
ibility. The molecular structures of the four components are given
in Figure 7. Quercetin and sucralose molecules possess free
hydroxyl groups which could act as potential proton donors for
hydrogen bonding. SDS has S=O groups and PVP has carbonyl
groups, and these could act as proton receptors. Therefore it can
be postulated that hydrogen bonding will occur within the core-
shell microparticles.
Quercetin molecules have both –OH groups and –C=O
groups, and so hydrogen bonds can form between drug molecules.
This can be verified from the ATR-FTIR spectra, in which sharp
peaks were visible for pure quercetin at 1669 and 1615 cm21
(Figure 7), representing the stretching vibrations of –C=O groups
when two molecules are bound together as dimers. However, all
the peaks for quercetin were absent in the spectra of the core-shell
microparticles. Only a single broad peak at 1654 cm21 can be
identified for M2, M3, and M5. This indicates that hydrogen
bonding occurs between the PVP carbonyl group and the hydroxyl
group of the quercetin molecule.
The disappearance of quercetin –C=O group bands, the shift
to lower wavenumbers of peaks assigned to the C=O stretching
vibrations in PVP (from 1663 cm21 to 1654 cm21), and the
reduced intensities of some peaks in the fingerprint region of the
quercetin spectrum clearly demonstrate that hydrogen bonding
exists in the microparticle samples.
The SDS C–H stretching bands at 2917 and 2850 cm21 and
the PVP C–H stretch at 2954 cm21 are not present in the
microparticles’ spectra. However a broader and weaker band at
2918 cm21 or 2917 cm21 can be seen in the spectra of M2, M3,
and M5. This is indicative of hydrophobic interactions between
the PVP and SDS molecules. Although electrostatic interactions
cannot be observed in the ATR-FTIR spectra, they must exist
between the negatively charged SDS head group and the d+
nitrogen atom on the pyrrolidone ring of PVP [44] and also
between the PVP oxygen and the electron poor C-19 of SDS [45],
as shown in Figure 7.
Based on the IR data, it is thus postulated that a combination of
hydrogen bonding, hydrophobic and electrostatic forces provide a
high degree of compatibility between the components that make
up the core-shell microparticles. This in turn creates a homoge-
neous structure which will enhance the stability of the composites
and ensure an even dispersion of the drug, thereby facilitating the
dissolution of quercetin from the microparticles.
In vitro dissolution properties
Quercetin has a UV absorbance peak at lmax = 371 nm; thus,
the amount of quercetin released from the microparticles can be
determined by UV spectroscopy using a predetermined calibration
curve: C= 15.95A – 0.0017 (R2=0.9997), where C is the quercetin
concentration (mg mL21) and A is the solution absorbance at
371 nm (linear range: 2 mg mL21 to 20 mg mL21). The measured
content of quercetin in all the microparticles was equivalent to the
calculated value, suggesting no drug loss during electrospraying.
Figure 9. In vitro permeation profiles of the quercetin powder
and the microparticles (n =6).
doi:10.1371/journal.pone.0092106.g009
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The in vitro drug release profiles of M2, M3 and M5 are provided
in Figure 8a. As anticipated, all the microparticles exhibit
extremely rapid release of the incorporated quercetin, freeing all
the drug within one minute. The results of an experiment to
observe visually the dissolution of quercetin from M5 are shown in
Figure 8b. The dissolution process is shown in sequence from 1 to
8. The time taken between the addition of 50 mg of M5 to
200 mL of dissolution medium and the formation of a uniform
yellow colored medium is less than 10s. In comparison, the crude
quercetin particles (size #100 mm) dissolved only slowly, reaching
30.4% release in one hour.
A schematic depticting the proposed drug release mechanisms is
given in Figure 8c. The core-shell microparticles have several key
properties allowing them to improve the dissolution rates of poorly
water-soluble drugs. First, the shell consists of PVP, SDS and
sucralose. All have good solubility in water. In particular SDS,
being a surfactant, not only facilitates the electrospraying process
through reducing the surface tension of the shell fluids, but also
enhances the hydrophilicity and wettability of the microparticles.
This promotes their rapid disintegration (diagram (I) in Figure 8c).
Second, the PVP matrix has hygroscopic and hydrophilic
properties, and PVP–water interactions (‘‘A’’ in Figure 8c (II))
are stronger than the polymer–drug attraction forces (‘‘B’’ in
Figure 8c (II)). Thus, the polymer chain can absorb solvent
molecules rapidly, increasing the volume of the polymer matrix
and allowing the polymer chains to loosen and uncoil. Water
molecules in the dissolution medium will replace the quercetin
molecules H-bonded to the –C=O groups of PVP (‘‘B’’ in
Figure 8c (II)), freeing the drug into solution. Quercetin molecules
will also form hydrogen bonds with water (‘‘C’’ in Figure 8c (II))
but this effect is very weak, as reflected by the drug’s poorly water
solubility.
In addition, the microparticles have small diameters and high
surface to volume ratios, which means that there is a large surface
area through which the drug can come into contact with the
dissolution medium. Finally the drug and the matrix polymer
formed amorphous composites, thereby removing the crystal
lattice energy that must be overcome for dissolution of the crude
quercetin powder. The latter is expected to dissolve through
gradual erosion of quercetin molecules from the crystal surfaces
(part (III) of Figure. 8c).
In vitro permeation properties
Comparisons of the in vitro permeation profiles of quercetin from
the microparticles and the pure powder are given in Figure 9. The
cumulative permeation percentages after 30 min for M2, M3, M5
and quercetin powder were 45.1%, 43.7%, 44.2% and 7.2%,
respectively. Regression values from linear release equations were
estimated and found to be as follows: QM2 = 1.5124t + 2.2453
(R= 0.9844, t#30 min), QM3 = 1.4515 t+2.6071 (R=0.9847,
t#30 min), QM5 =1.4676t+3.2051 (R= 0.9764, t#30 min) and
Qquercetin = 0.1501t+1.6889 (R= 0.9841, t#120 min), where Q is
the total permeation of quercetin in mg and t is the time in
minutes. The particles and quercetin powder had apparent
permeation rates of 0.5817, 0.5583, 0.5645 and 0.0577 mg
min21 cm22, respectively.
The microparticles yielded a permeation rate around 10-fold
faster than the quercetin powder. This is expected to be because
permeability across the sublingual mucosa is a passive diffusion
process, and hence faster dissolution of quercetin leads to an
increased concentration gradient of drug at the mucosal surface.
This facilitates rapid partitioning of drug into the sublingual
mucosa and subsequent permeation. The SDS in the shell of the
microparticles should also improve permeation by extracting some
of the intercellular lipids which can act as rate-limiting barrier to
the drug transport [46].
Although the composite microparticles M2, M3 and M5 have
slightly different sizes, this difference seems to exert little influence
on the in vitro dissolution and permeation rates of quercetin. This is
probably in large part because the size difference is small, but in
addition there is a homogeneous and amorphous distribution of
quercetin, and the PVP which comprises the bulk of the particles is
extremely hydrophilic. This results in the drug dissolving
synchronously with the polymer carrier, which is a very raid
process, and hence small differences in particle size do not affect
dissolution or permeation markedly. By the way, sucralose is
approved by FDA and is applied as a general-purpose sweetener in
foods, beverages, dietary supplements and medical foods [47]. The
presence of sucralose in the particle shells should thus provide an
acceptable taste for patients.
Conclusions
New fast-dissolving core-shell composite microparticles contain-
ing quercetin were successfully fabricated using coaxial electro-
spraying with a novel PVC-coated concentric spinneret. The
product cores consisted of PVP/quercetin and the shells of PVP/
SDS/sucralose. Although the quercetin-loaded solutions compris-
ing the particle cores were unprocessable using single fluid
electrospraying, the fact that the shell fluids could be processed
ensured successful coaxial spraying. The drug content in the
products can be tuned through the flow rate of the core solutions
(within an appropriate range) or the drug concentrations therein.
Particles were prepared with three different drug loadings of 7.64,
10.71, and 16.67% w/w. These had average diameters of
1.6961.13, 1.7461.02 and 1.8560.83 mm respectively. SEM
and TEM images clearly evidence the core/shell structure. The
components in both the core and the shell exist in an amorphous
physical form as a result of favorable interactions between them, as
demonstrated by XRD, DSC and ATR-FTIR. The microparticles
increased both the dissolution and permeation rates of quercetin.
Such materials thus have the potential to enhance the dissolution
and permeation performance of poorly water-soluble drugs, and to
be further developed as novel oral or sublingual drug delivery
systems.
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